Fatima Ghamlouche
Beirut, BA, Lebanon
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Integrated Phenotypic and Transcriptomic Profiling Positions ONC212 as a Lead Imipridone in Androgen-Independent Prostate Cancer Models.
Journal: International journal of molecular sciences
Published: March 01, 2026
Liquid biopsy in genitourinary cancers: Diagnostic and prognostic implications.
Journal: World journal of clinical oncology
Published: September 02, 2025
Effect of Inorganic Phosphorus Manipulation on the Growth and Progression of Prostate Cancer Cells In Vitro.
Journal: International journal of molecular sciences
Published: March 10, 2025
Repurposing piroxicam enhances the antineoplastic effects of docetaxel and enzalutamide in prostate cancer cells using 2D and 3D in vitro culture models.
Journal: Frontiers in cell and developmental biology
Published: January 09, 2025
ONC206, an imipridone derivative, demonstrates anti-colorectal cancer activity against stem/progenitor cells in 3D cell cultures and in patient-derived organoids.
Journal: Pharmacological reports : PR
Published: May 29, 2024
Prostate Cancer Organoids for Tumor Modeling and Drug Screening.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: March 13, 2024
MicroRNAs as clinical tools for diagnosis, prognosis, and therapy in prostate cancer.
Journal: Translational oncology
Published: September 15, 2022
Drug resistance in metastatic castration-resistant prostate cancer: an update on the status quo.
Journal: Cancer drug resistance (Alhambra, Calif.)
Published: February 08, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026